Bill Text: NY A00608 | 2023-2024 | General Assembly | Introduced

---

Bill Title: Relates to pharmacists administering medications approved by the U.S. Food and Drug Administration.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2023-03-03 - signed chap.5 [A00608 Detail]

Download: New_York-2023-A00608-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                           608

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                    January 10, 2023
                                       ___________

        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Higher Education

        AN  ACT  to amend the education law, in relation to medications approved
          by the U.S. Food and Drug Administration and administered  by  pharma-
          cists

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph b of subdivision 22 of section 6802 of the educa-
     2  tion law, as added by a chapter of the laws of 2022 amending the  educa-
     3  tion  law  relating  to  the  definition of the practice of pharmacy, as
     4  proposed in legislative bills  numbers  S.  4870-B  and  A.  3040-B,  is
     5  amended to read as follows:
     6    b. The injection of medications into the deltoid muscle for the treat-
     7  ment  of  mental  health  and  substance  use disorder, as prescribed or
     8  ordered by a licensed prescriber, acting within the scope of their prac-
     9  tice in this state and in accordance with regulations promulgated by the
    10  commissioner [and], in consultation with the department  of  health  [in
    11  consultation  with]  and any other state agencies as necessary, [but not
    12  be limited to, providing] provided that:
    13    (1) Such administration is conducted pursuant to a valid  prescription
    14  or order that authorizes a pharmacist to administer medications approved
    15  by  the  U.S.  Food  and Drug Administration for the treatment of mental
    16  health and substance  use  disorder  and  the  pharmacist  notifies  the
    17  licensed  prescriber that the administration is complete. Administration
    18  in a pharmacy may not commence until after the patient has received  the
    19  initial  injection  and is considered eligible for maintenance treatment
    20  by the licensed prescriber.
    21    (2) Such prescription may be subject to  reassessment  at  appropriate
    22  intervals, as determined by the licensed prescriber.
    23    (3) Such activity is conducted in accordance with regulations, promul-
    24  gated  or  adopted  by  the commissioner [and], in consultation with the

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04183-01-3
        A. 608                              2

     1  department of health[, in consultation with] and any other  state  agen-
     2  cies, as necessary, which shall include requirements for the following:
     3    (i)  Training  accredited  by  the  accreditation council for pharmacy
     4  education, that may include  educational  experiences  obtained  through
     5  pharmacy school curricula, or a similar health authority or professional
     6  body  appropriate  for  the  medications  being  administered  and their
     7  respective patient populations. Such training must  be  satisfactory  to
     8  the  commissioner and the department of health, in consultation with the
     9  board of pharmacy and any other  state  agencies,  as  necessary,  which
    10  shall  include, but not be limited to learning modules on techniques for
    11  administration by injections, indications, precautions, and  contraindi-
    12  cations  in  the use of agent or agents; record keeping and information;
    13  and  handling  emergencies,  including  anaphylaxis,  needle-sticks  and
    14  cardiopulmonary resuscitation.
    15    (ii) Maintaining continued competency regarding the populations served
    16  and medications administered.
    17    (iii)  Pre-administration  patient  consent  and  education  regarding
    18  common side effects, drug interactions,  injection  site  reactions  and
    19  other  information  routinely provided to patients upon dispensing. If a
    20  patient is unable to provide consent, the pharmacist must obtain consent
    21  from a person legally  responsible when the recipient  is  incapable  of
    22  consenting.
    23    (iv)  When  administering  an  injection in a pharmacy, the pharmacist
    24  shall provide an area for the injection that provides for the  patient's
    25  privacy.
    26    (v)  Record keeping and reporting of such administration by electronic
    27  transmission or facsimile to the patient's licensed prescriber, and,  to
    28  the extent practicable, make himself or herself available to discuss the
    29  outcome  of  such  injection,  including any adverse reactions, with the
    30  licensed prescriber acting within their scope of practice.
    31    (vi) Ensuring that only U.S. Food  and  Drug  Administration  approved
    32  medications are administered.
    33    §  2.  This  act  shall  take  effect on the same date and in the same
    34  manner as a chapter of the laws  of  2022  amending  the  education  law
    35  relating  to  the definition of the practice of pharmacy, as proposed in
    36  legislative bills numbers S. 4870-B and A. 3040-B, takes effect.